Clinical Trial Update: A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SAR 1118 ophthalmic solution in dry eye completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• SAR 1118

Snippet

Sponsor: Shire | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06